Home | Sitemap | Search | ContactA- A A+
   
 
    Public Member Support us  
 

IBCSG 19-01 

Phase III randomised double blind study of Letrozole versus placebo in women with primary breast cancer completing five or more years of adjuvant Tamoxifen

DESIGN

Design Trial 19-01

Results & Publications


Publications

Study Chair
Prof. Monica Castiglione - Bern, Switzerland

Trial Coordinator
Rita Pfister
IBCSG Coordinating Center, Bern, Switzerland
Phone: +41 31 389 93 91
Fax: +41 31 389 92 73
Email: rita.pfister@ibcsg.org

Date of Activation
September 3, 2001

Date of Closure
May 31, 2002

Targeted Accrual
4800 patients

Final Accrual
5031 patients


Results Publications Results & Publications


News

18.03.2017:
The next IBCSG Annual Meeting will take place in Vienna, Austria on March 18 and 19, 2017 .

15.03.2017:
15th St.Gallen International Breast Cancer Conference 15-18 March 2017 in Vienna/Austria  

30.09.2016:
Benefiz-Gala mit Spitzenkoch Anton Mosimann Freitag 30. September 2016 im Park Hyatt

All News

 
  Print